PHAR
Pharming Group NV
NASDAQ: PHAR · HEALTHCARE · BIOTECHNOLOGY
$16.36
-0.40% today
Updated 2026-04-29
Market cap
$1.16B
P/E ratio
408.88
P/S ratio
3.07x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$9 – $21
Volume
0.0M
Pharming Group NV (PHAR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $40.96M | $104.37M | $166.72M | $93.40M | $80.07M | $49.59M | $32.01M | $22.28M | $43.37M | $67.75M | $63.06M | $133.34M | $199.38M | $245.45M | $255.91M | $342.55M | $397.31M | $425.80M | $462.85M | $399.99M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $30.22M | $55.97M | $114.75M | $50.08M | $40.93M | $38.90M | $17.06M | $11.17M | $33.97M | $59.76M | $55.86M | $65.41M | $105.87M | $132.05M | $119.44M | $215.47M | $249.44M | $277.50M | $316.34M | $278.44M |
| Total liabilities | $6.93M | $38.59M | $116.14M | $75.96M | $60.99M | $36.16M | $33.55M | $32.40M | $36.45M | $31.46M | $37.00M | $104.45M | $176.82M | $174.81M | $138.53M | $192.39M | $204.40M | $221.16M | $244.07M | $178.92M |
| Current liabilities | $6.76M | $12.13M | $34.33M | $17.47M | $51.97M | $12.88M | $10.54M | $11.86M | $17.85M | $18.09M | $14.73M | $54.03M | $70.22M | $94.49M | $114.25M | $62.91M | $46.77M | $59.70M | $77.97M | $73.80M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | $58.68M | $37.27M | $0.00 | $121.93M | $122.65M | $131.62M | $136.60M | $78.15M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-190.89M | $-238.75M | $-313.88M | $-316.79M | $-375.48M | $-320.80M | $-334.93M | $-348.82M | $-370.23M | $-311.94M | $-288.35M | $-293.45M | $-427.42M | $-381.65M | $-340.71M | $-221.85M | $-273.17M | $-256.43M | $-265.26M | $-275.49M |
| Accounts receivable | $1.14M | $0.00 | — | $0.00 | $0.00 | $3.28M | $830242.00 | $538260.00 | $849236.00 | $1.71M | $3.27M | $11.97M | $12.22M | $18.30M | $28.86M | $19.25M | $27.59M | $25.33M | $42.62M | $50.17M |
| Inventory | $4.57M | $12.10M | $17.09M | $15.27M | $16.13M | $11.99M | $8.53M | $2.78M | $6.58M | $16.30M | $17.74M | $18.87M | $22.00M | $19.81M | $16.22M | $17.32M | $27.31M | $42.33M | $56.76M | $55.72M |
| Goodwill | — | $12.13M | $13.40M | $9.74M | $6.18M | — | — | — | — | — | — | — | — | — | — | — | $-87029.00 | — | — | — |